Dublin, June 19, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Prefilled Syringes Market, Analysis & Forecast, 2017-2021 (Focus on Type, Design, Material both (Value & Volume) and Patent Landscape)" report to their offering.
The global market for prefilled syringes is expected to grow at a CAGR of 10.75% from 2017 to 2021
The prefilled syringes market is growing exponentially worldwide due to the increase in prevalence of chronic diseases, growing demand and higher production of large molecule biologics and biosimilars, high penetration rate of self-injection devices and continuous advancement in prefilled syringes with the inclusion of autonomous inbuilt safety mechanisms. The global prefilled syringes market has been segmented into four major regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW).The European and North American markets are dominant in terms of market share, which is attributed to the presence of leading prefilled syringes and biological drug manufacturing players in both the regions.
Syringe manufacturers provide prefillable syringes in pre-sterilized or bulk forms to drug manufacturers for filling of various categories of injectable drugs including anticoagulants, vaccines, antivirals, hematopoietics, monoclonal antibodies and some other emergency drugs.
The increasing demand for safety plastic prefilled syringes due to its convenience and cost effectiveness have obligated companies to focus on new product developments and innovations. The most prominent opportunity for the industry players is market penetration in emerging markets such as Japan, China, Australia and India. Currently, the market is dominated by Europe due to the presence of established prefilled syringe and biological drug manufacturers based in Europe. However, stringent regulatory standards regarding combination products and high manufacturing cost of prefilled syringes are hampering the growth of the market. Market penetration, establishment and outreach of major key players in the emerging markets, and increasing biologics and bio-similar in the market will serve as viable opportunities for the market players to enhance their business in the future.
The key players are Gerresheimer AG, Schott AG, Stevanato Group, Baxter International, Inc., Unilife Corporation, Terumo Corporation, West Pharmaceuticals, Inc., Vetter pharmaceuticals and Becton Dickinson and Co, among others.
Key Topics Covered:
Executive Summary
1 Research Scope and Methodology
2 Market Overview
2.1 Introduction
2.2 Advantages of Prefilled Syringes over traditional vial & syringe system
2.3 Manufacturing & Packaging Challenges of Prefilled Syringes
2.4 Benefits of prefilled syringes to the drug makers
2.5 Technology Trends in Market
2.6 Legal Requirements and Regulations
2.7 Patent Analysis
3 Market Dynamics
4 Competitive Landscape
4.1 Key Market Development and Strategies
4.1.1 Mergers and Acquisition
4.1.2 Product Launch & Developments
4.1.3 Partnerships, Collaborations & Joint Ventures
4.1.4 Business Expansions and Contracts
4.2 Market Share Analysis
4.3 Industry Attractiveness
5 Industry Analysis
5.1 Regulatory Bodies and Associations
5.2 Patent Landscape
6 Global Prefilled Syringes by Type, 2016-2023 (Qualitative)
6.1 Overview
6.2 Conventional Prefilled Syringes
6.3 Safety Prefilled Syringes
7 Global Prefilled Syringes by Design, 2016-2023 (Qualitative)
7.1 Overview
7.2 Single-Chamber Prefilled Syringes
7.3 Dual-Chamber Prefilled Syringes
7.4 Customized Prefilled Syringes
8 Global Prefilled Syringes by Material Revenue ($Million) and Volume (Million Units), 2016-2023
8.1 Overview
8.2 Glass Prefilled Syringes
8.3 Plastic Prefilled Syringes
9 Global Prefilled Syringes Market by Region, Revenue ($Million) and Volume (Million Units), 2016-2023
9.1 Overview
9.2 North America
9.3 Europe
9.4 Asia Pacific (APAC)
9.5 Rest of the World (RoW)
10 Company Profiles
10.1 Baxter International
10.2 Becton Dickinson & Company
10.3 Bristol Myers Squibb
10.4 Eli Lilly
10.5 Gerresheimer
10.6 Medtronic Inc.
10.7 Nipro Corporation
10.8 Pfizer
10.9 SCHOTT AG
10.1 Stevanto Group
10.11 Terumo Corporation
10.12 Unilife Corporation
10.13 Vetter Pharmaceuticals GmBH
10.14 Weigao Group
10.15 West Pharmaceutical Services
10.16 Snapshot of Other Key Players
Companies Mentioned
- Baxter International
- Becton Dickinson & Company
- Bristol Myers Squibb
- Eli Lilly
- Gerresheimer
- Medtronic Inc.
- Nipro Corporation
- Pfizer
- SCHOTT AG
- Stevanto Group
- Terumo Corporation
- Unilife Corporation
- Vetter Pharmaceuticals GmBH
- Weigao Group
- West Pharmaceutical Services
For more information about this report visit https://www.researchandmarkets.com/research/xr4kdq/global_prefilled
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.